# Celebrex and HO Study

> **NCT05648916** · — · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 200 (estimated)

## Conditions studied

- Heterotopic Ossification

## Interventions

- **OTHER:** Celecoxib

## Key facts

- **NCT ID:** NCT05648916
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-02
- **Primary completion:** 2023-08
- **Final completion:** 2023-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05648916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05648916, "Celebrex and HO Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05648916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*